liposome entrapped docetaxel

Liposome entrapped docetaxel (LE-DT) is a formulation of the chemotherapeutic agent docetaxel encapsulated within liposomes. This approach aims to improve the solubility and pharmacokinetics of docetaxel while reducing toxicity associated with conventional formulations that use solvents like Tween 80. Liposomal encapsulation can provide sustained drug release, protection from degradation and toxicities, and may help overcome multidrug resistance. Preclinical studies have shown improved anti-tumor effects and reduced toxicity compared to free docetaxel. Clinical trials in patients with advanced solid tumors demonstrated that LE-DT is generally well tolerated with expected toxicities such as neutropenia but less neuropathy or edema than standard formulations. The mechanism of action remains inhibition of tubulin polymerization leading to cell cycle arrest[2][4][5][6][7].

Other names

liposomal docetaxeldocetaxel liposomalliposome-encapsulated docetaxelDTX-liposomeDocetaxel injection concentrate for nanodispersionDocetaxel nanodispersion